TL;DR
This paper reveals a novel epigenetic mechanism for rapid gene activation during inflammatory responses. They discovered that phosphorylation of a specific serine residue (S31) on the H3.3 histone variant, H3.3S31ph, acts as a signal to recruit and activate the SETD2 enzyme, which in turn promotes H3K36 trimethylation. This coordinated histone modification process is crucial for efficiently boosting the transcription of inflammatory genes.
What Problem Does This Paper Address?
When our bodies encounter threats like pathogens, they need to quickly ramp up the production of specific genes to mount an effective defense. This rapid, selective gene activation is a complex process, especially given that our genomes are densely packed with DNA wrapped around histone proteins. While we know that the H3.3 histone variant is enriched at inflammatory genes, the precise mechanisms by which it facilitates this rapid and high-level transcription have remained unclear. Specifically, the role of a unique serine residue (S31) present in H3.3 but not in canonical H3.1/2 histones, and its potential post-translational modifications, were unknown. This paper aims to uncover how H3.3 contributes to the dynamic regulation of chromatin that enables swift transcriptional responses.
Methods
The researchers employed a multi-pronged approach:
- Mass Spectrometry (MS): Used to identify and quantify histone post-translational modifications (PTMs) in both resting and LPS-stimulated mouse macrophages, with a focus on H3.3S31ph.
- Western Blotting: To confirm the stimulation-induced nature and kinetics of H3.3S31ph, paralleling known signaling events like ERK phosphorylation.
- Chromatin Immunoprecipitation followed by Sequencing (ChIP-seq): To map the genomic locations of H3.3S31ph and other histone marks (like H3S28ph) in stimulated versus resting cells, revealing where these modifications are deposited.
- RNA sequencing (RNA-seq): To measure gene expression levels and identify LPS-induced genes, and to assess the impact of H3.3 depletion on this induction.
- Biochemical Assays: In vitro enzymatic assays using recombinant SETD2 and H3.3-containing nucleosomes to study the direct interaction and catalytic activity.
- X-ray Crystallography: To determine the high-resolution structure of the SETD2 catalytic domain bound to a modified H3.3 peptide, revealing the molecular basis of the interaction.
- CRISPR/Cas9 Gene Editing: To generate H3.3 knockout and hypomorphic cell lines to study the functional requirement of H3.3 in inflammatory gene induction.
- siRNA Knockdown: To assess the role of SETD2 in the expression of LPS-induced genes.
Datasets
- Mouse Bone Marrow Derived Macrophages (BMDM): Used for various experiments including MS, Western blotting, ChIP-seq, and RNA-seq.
- RAW264.7 cell lines: Used for generating H3.3 knockout and hypomorphic models.
- HeLa Kyoto cells: Used for immunofluorescence microscopy and chromosome spreads.
Key Insights and Ideas
- H3.3S31ph as a "Danger Signal": The phosphorylation of H3.3 at serine 31 (H3.3S31ph) is not a constitutive mark but specifically appears on genes that are rapidly induced upon stimulation, acting as a signal of cellular activation.
- Direct Engagement of SETD2: H3.3S31ph directly interacts with the histone methyltransferase SETD2, a key enzyme in H3K36 trimethylation. This is a direct link between a histone modification and an enzymatic machinery.
- Structural Basis for Specificity: The crystal structure revealed a conserved positively charged cleft in SETD2 that specifically recognizes the phosphorylated serine on H3.3, explaining how SETD2 preferentially binds to and acts on H3.3S31ph nucleosomes.
- H3.3 is Essential for Rapid Gene Induction: Depletion of H3.3 in macrophages significantly impairs the induction of inflammatory genes, highlighting its critical role beyond simply being a structural component.
- Dedicated Epigenetic Mechanism: The findings suggest that H3.3S31ph and its interaction with SETD2 represent a dedicated epigenetic mechanism that grants stimulation-induced genes preferential access to the transcription machinery, enabling rapid and robust expression.
Key Results
- H3.3S31ph is specifically deposited along the gene bodies of rapidly induced response genes in mouse macrophages stimulated by pathogen sensing.
- This phosphorylation mark directly engages SETD2, leading to preferential methylation of H3K36 on H3.3S31ph nucleosomes.
- The crystal structure of SETD2 bound to H3.3S31ph revealed a specific interaction mediated by conserved lysine residues in SETD2.
- Mutating these key lysine residues in SETD2 significantly reduced its ability to be stimulated by H3.3S31E.
- Knockdown of SETD2 in macrophages impaired the expression of LPS-induced genes that are marked by H3.3S31ph.
- H3.3 knockout or hypomorphic cell lines showed a substantial decrease in the induction of LPS-induced genes.
- Genes with the highest levels of H3.3S31ph showed the most significant decrease in expression in H3.3 deficient cells.
Limitations and Future Work
- Signaling Pathways: While the study identifies H3.3S31ph as a signal, the specific kinase(s) responsible for its phosphorylation in response to stimulation remain to be fully elucidated.
- Breadth of Mechanisms: The authors acknowledge that the described mechanisms might not be exhaustive and further research is needed to understand the full spectrum of H3.3's role in chromatin regulation across different species and cell types.
- Functional Significance of H3.3 Variants: The study focused on H3.3 and its S31 residue. Further investigation into the relative contributions of different H3.3 variants and their specific modifications could provide deeper insights.
- Therapeutic Implications: The findings have implications for understanding and treating inflammatory diseases, suggesting that targeting these specific epigenetic mechanisms could offer novel therapeutic strategies.
Summary updated